BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23732617)

  • 1. Nitric oxide inhibits CXCL12 expression in neuroinflammation.
    Petković F; Blaževski J; Momčilović M; Mostarica Stojkovic M; Miljković D
    Immunol Cell Biol; 2013 Jul; 91(6):427-34. PubMed ID: 23732617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12-γ expression is inhibited in neuroinflammation.
    Timotijević G; Petković F; Blaževski J; Momčilović M; Mostarica Stojković M; Miljković D
    Brain Res; 2013 Jun; 1519():120-6. PubMed ID: 23651977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12 expression within the CNS contributes to the resistance against experimental autoimmune encephalomyelitis in Albino Oxford rats.
    Miljković D; Stanojević Z; Momcilović M; Odoardi F; Flügel A; Mostarica-Stojković M
    Immunobiology; 2011 Sep; 216(9):979-87. PubMed ID: 21601937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor stimulates expression of CXCL12 in astrocytes.
    Blaževski J; Petković F; Momčilović M; Jevtić B; Mostarica Stojković M; Miljković D
    Immunobiology; 2015 Jul; 220(7):845-50. PubMed ID: 25662914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.
    Mueller AM; Yoon BH; Sadiq SA
    J Biol Chem; 2014 Aug; 289(33):22888-22899. PubMed ID: 24973214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.
    Lubina-Dąbrowska N; Stepień A; Sulkowski G; Dąbrowska-Bouta B; Langfort J; Chalimoniuk M
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):325-338. PubMed ID: 28299403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 in control of neuroinflammation.
    Momcilović M; Mostarica-Stojković M; Miljković D
    Immunol Res; 2012 Apr; 52(1-2):53-63. PubMed ID: 22392052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
    Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
    J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Src-suppressed C kinase substrate in experimental autoimmune encephalomyelitis: a link between release of astrocyte proinflammatory factor and oligodendrocyte apoptosis.
    Li X; Yan M; Hu L; Sun L; Zhang F; Ji H; Jiang J; Wang P; Liu H; Gao Y; Tao T; He X; Cheng C; Shen A
    J Neurosci Res; 2010 Jul; 88(9):1858-71. PubMed ID: 20155814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
    Blaževski J; Petković F; Momčilović M; Paschke R; Kaluđerović GN; Mostarica Stojković M; Miljković D
    Acta Pharmacol Sin; 2013 Mar; 34(3):424-31. PubMed ID: 23377550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Confers Resistance of Albino Oxford Rats to the Induction of Experimental Autoimmune Encephalomyelitis.
    Stanisavljević S; Dinić M; Jevtić B; Đedović N; Momčilović M; Đokić J; Golić N; Mostarica Stojković M; Miljković Đ
    Front Immunol; 2018; 9():942. PubMed ID: 29770137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.
    Stosic-Grujicic S; Ramic Z; Bumbasirevic V; Harhaji L; Mostarica-Stojkovic M
    Clin Exp Immunol; 2004 Apr; 136(1):49-55. PubMed ID: 15030513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p38 MAPK induced peroxynitrite generation in LPS plus IFN-gamma-stimulated rat primary astrocytes via activation of iNOS and NADPH oxidase.
    Yoo BK; Choi JW; Shin CY; Jeon SJ; Park SJ; Cheong JH; Han SY; Ryu JR; Song MR; Ko KH
    Neurochem Int; 2008 May; 52(6):1188-97. PubMed ID: 18289732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
    Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
    Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis.
    Medina-Fernández FJ; Luque E; Aguilar-Luque M; Agüera E; Feijóo M; García-Maceira FI; Escribano BM; Pascual-Leone Á; Drucker-Colín R; Túnez I
    Life Sci; 2017 Jan; 169():20-26. PubMed ID: 27876534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556.
    Brenner T; Poradosu E; Soffer D; Sicsic C; Gazit A; Levitzki A
    Exp Neurol; 1998 Dec; 154(2):489-98. PubMed ID: 9878184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
    Gao Q; Zhang Y; Han C; Hu X; Zhang H; Xu X; Tian J; Liu Y; Ding Y; Liu J; Wang C; Guo Z; Yang Y; Cao X
    J Autoimmun; 2016 May; 69():74-85. PubMed ID: 26994903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective arylpiperazine dopaminergic/serotonergic ligands suppress experimental autoimmune encephalomyelitis in rats.
    Popovic M; Stanojevic Z; Tosic J; Isakovic A; Paunovic V; Petricevic S; Martinovic T; Ciric D; Kravic-Stevovic T; Soskic V; Kostic-Rajacic S; Shakib K; Bumbasirevic V; Trajkovic V
    J Neurochem; 2015 Oct; 135(1):125-38. PubMed ID: 26083644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.